Who invested in Biolevate?
Biolevate, a HealthTech startup from France, raised €30M in a Series A round announced on 22 September 2026. Investors: Orange Ventures (lead), MSD Global Health Innovation Fund (MGHIF), STATION F, EQT Ventures, MSD Global Health Innovation Fund and 1 more named in the source.
Biolevate
€30MSeries AHealthTechOrange VenturesleadMSD Global Health Innovation Fund (MGHIF)STATION FEQT VenturesMSD Global Health Innovation Fund · +1 more in the source
Francetech.eu
Questions founders ask
- Who invested in Biolevate?
- Orange Ventures, MSD Global Health Innovation Fund (MGHIF), STATION F, EQT Ventures and MSD Global Health Innovation Fund invested in Biolevate's Series A round, announced on 22 September 2026 (source: tech.eu).
- Who led Biolevate's Series A round?
- Orange Ventures, according to tech.eu.
- How much did Biolevate raise?
- €30M in its Series A round, as reported by tech.eu.
Raising next? See which investors fit your round.
In 30 minutes you'll know which funds matter for your round.
Request accessRounds are read from public funding coverage and matched against our investor database. Every line links to the article it came from — that article, not this page, is the source. Amounts are quoted exactly as the article stated them; we do not convert currencies. Individual angel investors named in an article are not listed here.
Something wrong? Tell us what to correct and we will fix it. To be removed from Oka entirely, use /remove-me.